In summary, through extensive testing, we discovered that miR-125a-5p targets HK2, affects gene expression in the DDR pathway, targeting miR-125a-5p has been demonstrated to augment the radiosensitivity of LSCC cells, thereby potentially ameliorating the therapeutic efficacy in patients afflicted with laryngeal cancer. Here, HK2 is linked to laryngeal carcinoma.